Editorial Policy | Wunder
Editorial Policy
Wunder publishes educational content about botanical compounds, legal entheogens, and supplement safety. This page explains how that content is researched, written, reviewed, and updated — and who is responsible for it.
Who writes our content
Our educational articles are written by Sage Mercer, who creates and reviews content for Wunder's /blogs/learn/ collection. Sage has a background in botanical health and has written on kava, blue lotus, kanna, amanita muscaria, and related compounds since 2022.
Wunder is a supplement company. Sage writes for Wunder. That relationship is disclosed in every article byline. We do not use anonymous contributors or AI to author final published content without human review.
How we research articles
Each article in the /blogs/learn/ collection is researched using:
- Peer-reviewed studies sourced from PubMed, the National Library of Medicine, and published pharmacology journals
- Primary regulatory documents from the FDA, DEA, and relevant state agencies
- Established reference texts in ethnobotany and pharmacognosy
We cite our sources directly in the article body. Citations follow a format of author, year, and source title. Where a study is paywalled, we link to the abstract.
We do not use unnamed "experts" or unattributed "research suggests" claims. If we can't cite it, we don't publish it.
How we handle health claims
Wunder's products are dietary supplements. Nothing we publish is medical advice, and we do not make therapeutic claims.
We describe what research says compounds do in studies. We do not tell readers what to take or what will happen to them. If a study showed a compound had a specific effect at a specific dose in a specific population, we say that — with the citation. We don't generalize it to "you will feel X."
Our content covers legal status, compound mechanisms, safety considerations, and consumer guidance. When safety data is limited, we say so.
Our AI writing audit process
We run every piece of content through a structured AI writing audit before publishing. This audit checks for AI-generated writing patterns that reduce credibility and readability, including vague claims, hollow intensifiers, and generic transitions.
Content that fails the audit is rewritten before it goes live. We don't publish first drafts.
This process exists because Google's 2026 core update specifically evaluates content quality signals, and because our readers deserve content that was actually written with care, not generated and published without review.
How we update content
We update articles when:
- Regulatory status changes (state or federal)
- New peer-reviewed research is published on a compound we cover
- A reader or fact-checker identifies an error
When an article is updated, we note the original publication date and the most recent update date at the top of the piece. We do not quietly rewrite articles without indicating changes were made.
What we won't publish
- Medical advice or dosing recommendations for specific individuals
- Therapeutic claims for Wunder products
- Content that misrepresents the legal status of any compound
- Content designed to rank for keywords rather than answer real questions
Contact us
If you find an error in any of our articles, or if you'd like to flag a factual concern, contact us at hello@ourwunderland.com. We review every submission.
Last updated: April 2026